Erratum: Biological activity of the thyroid TRK-T3 oncogene requires signalling through ShcRoccato, E; Miranda, C; Ranzi, V; Gishizki, M; Pierotti, M A; Greco, A
doi: 10.1038/bjc.2016.131pmid: 27228298
Correction to: British Journal of Cancer (2002) 87, 645–653. doi:10.1038/sj.bjc.6600544; published online 3 September 2002 The corresponding author of the above paper, Dr Angela Greco, has informed us that due to an inadvertent and minor error in the preparation of the figure, the images labelled ‘T3/Y291F’ and ‘Mock’ in Figure 2B are probably duplicates.
Erratum: Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladderHafeez, S; Horwich, A; Omar, O; Mohammed, K; Thompson, A; Kumar, P; Khoo, V; Van As, N; Eeles, R; Dearnaley, D; Huddart, R
doi: 10.1038/bjc.2016.132pmid: 27228294
Correction to: British Journal of Cancer (2015) 112, 1626–1635. doi:10.1038/bjc.2015.109; published online 21 April 2015 Updated online 26 May 2016: This article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.
Erratum: Polygenic susceptibility to testicular cancer: implications for personalised health careLitchfield, Kevin; Mitchell, Jonathan S; Shipley, Janet; Huddart, Robert; Rajpert-De Meyts, Ewa; Skakkebæk, Niels E; Houlston, Richard S; Turnbull, Clare
doi: 10.1038/bjc.2016.136pmid: 27228286
Correction to: British Journal of Cancer (2015) 113, 1512–1518. doi:10.1038/bjc.2015.334; published online 13 October 2015 Updated online 26 May 2016: This article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.